Shingrix, a new shingles vaccine that boasts overwhelming preventive effects, will be officially released in December. It is expected to shake the game of shingles vaccines by showing a 97% prevention effect, which is twice that of existing vaccines, and proving long-term effectiveness and safety. On the other hand, prices are more than four times higher and small initial supplies are considered barriers. According to the pharmaceutical industry on the 17th, GSK will release a new shingles vaccine, Shingrix, in Korea in December. It has been a year and three months since it was approved by the Ministry of Food and Drug Safety in Korea. Shingrix is an antigen of Glycoprotein E, a protein component of chickenpox and shi